SM

Shivam Mittal

Active Director Director DIN 09098435
DIN 09098435 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Shivam Mittal

Data last updated:

Shivam Mittal is a Director at Kiaora Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Kiaora Pharmaceuticals Private Limited reported revenue of ₹63.3 Lakh (FY 2025).

DIN 09098435
Primary Designation Director
Industry Trading
First Appointment 09 Mar 2021
Oldest Company Age 20 yrs
Largest company Kiaora Pharmaceuticals Private Limited · ₹63.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20212005₹63.3 Lakh (FY 2025)Active

Board colleagues of Shivam Mittal

Directorship timeline

Open interactive timeline →
Kiaora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shivam Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivam Mittal

Shivam Mittal currently holds 1 directorship: Kiaora Pharmaceuticals Private Limited (Director, since 09 Mar 2021, revenue ₹63.3 Lakh (FY 2025)).

Shivam Mittal was first appointed on 09 Mar 2021 as Director at Kiaora Pharmaceuticals Private Limited.

The current boards of Shivam Mittal's companies include Leena Mittal (Kiaora Pharmaceuticals Private Limited), Pradumn Kumar Mittal (Kiaora Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available